An Integrated Health, Trade andIP Approach to Respond to theCOVID‑19 Pandemic - Second update, May 2023
14 July 2023
| Technical document
Overview
The second edition of the joint WHO, WIPO and WTO publication Promoting Access to Medical Technologies and Innovation: Intersections Between Public Health, Intellectual Property and Trade (the Trilateral Study),* published in 2020, included a special insert that mapped the challenges posed by the COVID‑19 pandemic in relation to the integrated health, trade and intellectual property (IP) policy framework set out in the Trilateral Study.
The Trilateral Study and the special insert were designed to serve as background reference for policymakers in the widest sense – lawmakers, government officials, delegates to international organizations, nongovernmental organizations and researchers who seek a comprehensive presentation of the full range of issues,
including institutions and legal concepts with which they may be unfamiliar. They were also designed to serve as a factual resource for the three organizations’ technical cooperation activities.
This update revises the information contained in the last version, launched in October 2021**, in the light of more recent developments as of 17 May 2023.
WHO Team
Health Product Policy and Standards (HPS),
Medicines Selection, IP and Affordability (MIA)
Number of pages
34